🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Screen. Find. Treat. Lack of disease awareness and screening opportunities too often create a barrier to early diagnosis and treatment. Together with Blavity, we support the #GetScreened campaign by American Cancer Society to raise cancer awareness in the Black community.

Novartis is one of seven pharmaceutical companies that are collaborating to established the INTREPID Alliance, which aims to accelerate progress in discovery and development of new antiviral treatments for future pandemics. Read more: bit.ly/3JSLG98

#Sicklecell disease can leave those impacted feeling alone. That’s why tackling a chronic condition like this demands us to join forces as a global community to better serve patients’ needs. Learn more. #SickleCellAwareness #AccessBarriers

Healthcare should not be a privilege. It’s a fundamental human right. Yet, many systemic barriers prevent people from accessing the healthcare they need. Watch to learn how public-private partnerships are helping to overcome barriers to healthcare for the long-term. #UNGA78

.Peter Sands of The The Global Fund highlights a vital mission. Diseases like AIDS, TB, and malaria continue to cause immense suffering. This decade is crucial to our commitment to #EndMalaria. With joint efforts and investment, achieving #HealthForAll by 2030 is within our grasp.

People affected by Chagas disease face barriers to diagnosis and treatment, meaning they can go years without being treated. This can lead to Chronic Chagas Cardiomyopathy, the most severe #Chagas complication. We are working with partners to change this through education and

Millions of lives, billions of dollars: heart disease places a massive toll on our global community, yet is not thoroughly addressed. For #WorldHeartDay, Ann Aerts, MD explored potential root causes for this paradox in her article for @PharmaPhorum– and perspectives for a way out.

For over a decade, Novartis and the Universität Basel have conducted the Next Generation Scientist program, welcoming 227 students from 34 countries since 2011, including a recent cohort from Ghana, South Africa, Argentina, and Peru. The initiative not only strengthens interns'

Over a decade, Novartis & Universität Basel's Next Generation Scientist Program welcomed students from 34 countries, including Ghana, South Africa, Argentina, & Peru. The program boosts research skills and enhances your scientific expertise. Apply here: bit.ly/46WQWlI

For a decade, Novartis amd Universität Basel have championed the Next Generation Scientist program, fostering the scientific and professional growth of young scholars from low- and middle-income nations. Watch this video to hear from this year's postgraduate cohort. To enhance your

Novartis and Medicines for Malaria Venture (MMV) have announced positive data from the trial of a treatment for the tiniest babies with #malaria. This brings us one step closer to ensuring all people can realize their right to an effective malaria treatment. #WorldMalariaDay EDCTP

The progress the global community has made against #malaria in the past 25 years is nothing short of extraordinary. But we’ve stalled. Let’s come together to finally outsmart the mosquito. #WorldMalariaDay RBM Partnership Harvard's Defeating Malaria Initiative @MalariaLeaders

From the battlefields of Vietnam to the shores of Kenya, the fight against malaria has been marked by highs and lows. We remain committed to the end goal: eliminating malaria. #WHA77 #EndMalaria #Malaria Harvard T.H. Chan School of Public Health RBM Partnership